{"id":"https://openalex.org/W4310109057","doi":"https://doi.org/10.1182/blood-2022-168932","title":"A Phase1/1b Dose Escalation/Dose Expansion Study of Prgn-3007 Ultracar-T Cells in Patients with Advanced Hematologic and Solid Tumor Malignancies","display_name":"A Phase1/1b Dose Escalation/Dose Expansion Study of Prgn-3007 Ultracar-T Cells in Patients with Advanced Hematologic and Solid Tumor Malignancies","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310109057","doi":"https://doi.org/10.1182/blood-2022-168932"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-168932","doi":"https://doi.org/10.1182/blood-2022-168932","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-168932","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055948859","display_name":"Javier Pinilla Ibarz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Javier Pinilla Ibarz","raw_affiliation_strings":["1Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","2Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","3Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"2Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"3Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084546808","display_name":"Amy R. Lankford","orcid":"https://orcid.org/0000-0001-9896-6193","observed_orcids":["https://orcid.org/0000-0001-9896-6193"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amy Lankford","raw_affiliation_strings":["4Precigen, Inc, Germantown, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Precigen, Inc, Germantown, MD","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109110971","display_name":"Helen Sabzevari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helen Sabzevari","raw_affiliation_strings":["4Precigen, Inc, Germantown, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Precigen, Inc, Germantown, MD","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025137989","display_name":"Bijal Dinesh Shah","orcid":"https://orcid.org/0000-0003-4328-6021","observed_orcids":["https://orcid.org/0000-0003-4328-6021"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bijal D. Shah","raw_affiliation_strings":["5Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090789911","display_name":"Hatem Hussein Soliman","orcid":"https://orcid.org/0000-0001-6644-2264","observed_orcids":["https://orcid.org/0000-0001-6644-2264"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hatem Soliman","raw_affiliation_strings":["6Breast Oncology, Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Breast Oncology, Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084789778","display_name":"Julio C. Ch\u00e1vez","orcid":"https://orcid.org/0000-0002-2045-6238","observed_orcids":["https://orcid.org/0000-0002-2045-6238"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julio C. Chavez","raw_affiliation_strings":["5Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","7Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"7Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082452338","display_name":"Rutul R. Shah","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rutul R Shah","raw_affiliation_strings":["4Precigen, Inc, Germantown, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Precigen, Inc, Germantown, MD","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.3154,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.56181638,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":96},"biblio":{"volume":"140","issue":"Supplement 1","first_page":"7486","last_page":"7487"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ror1","display_name":"ROR1","score":0.9520000219345093},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.9210000038146973},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.6230000257492065},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7400000095367432},{"id":"https://openalex.org/keywords/dose-expansion","display_name":"dose expansion","score":0.7289999723434448},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.8220000267028809},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/il-15","display_name":"IL-15","score":0.8479999899864197},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.824999988079071},{"id":"https://openalex.org/keywords/kill-switch","display_name":"kill switch","score":0.9279999732971191},{"id":"https://openalex.org/keywords/nonviral-gene-delivery","display_name":"non-viral gene delivery","score":0.7820000052452087},{"id":"https://openalex.org/keywords/b-cell-acute-lymphoblastic-leukemia","display_name":"B-cell acute lymphoblastic leukemia","score":0.722000002861023},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.8140000104904175}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7017042636871338},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5871187448501587},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.5859817862510681},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5048192143440247},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.4211265444755554},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.42059704661369324},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.3412894010543823},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3312120735645294},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2923300862312317},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2597675025463104}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-168932","doi":"https://doi.org/10.1182/blood-2022-168932","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-168932","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3210596056","https://openalex.org/W2887094020","https://openalex.org/W4403810670","https://openalex.org/W2792105646","https://openalex.org/W2944614129","https://openalex.org/W4321238242","https://openalex.org/W2979539238","https://openalex.org/W3023666283","https://openalex.org/W4308376798","https://openalex.org/W4200313648"],"abstract_inverted_index":{"Background:":[0],"Receptor":[1],"tyrosine":[2],"kinase-like":[3],"orphan":[4],"receptor":[5,194],"1":[6,228],"(ROR1)":[7],"is":[8,44,139,178,185,345],"a":[9,170,190,208,216,279,325,346,501],"promising":[10],"target":[11],"for":[12,201,211,219,473,482,538,558],"cancer":[13,104],"treatment":[14,161],"as":[15,35,64,455],"its":[16],"expression":[17,52,87,115,243,400],"enhances":[18],"tumor":[19,122,128,261,286,295,333,534],"cell":[20,72,82,155,225,310,567],"growth":[21],"and":[22,27,29,39,80,110,120,131,160,169,184,206,215,249,259,267,288,324,358,374,378,413,470,518,531,565,569,577],"survival,":[23],"promotes":[24],"epithelial-mesenchymal":[25],"transition":[26],"metastasis":[28,130],"participates":[30],"in":[31,46,55,60,91,118,203,241,303,332,364,491,512,525,527,545],"pro-survival":[32],"pathways":[33],"such":[34,63],"PI3-Kinase/AKT,":[36],"EGFR":[37],"signaling,":[38],"the":[40,143,220,271,356,519,528,532,546,551,573],"p38-MAPkinase":[41],"pathway.":[42],"ROR1":[43,54,117,246,301,402],"undetectable":[45],"normal":[47],"adult":[48],"tissues,":[49],"however":[50],"aberrant":[51],"of":[53,116,145,223,282,294,308,317,330,360,401,421,426,550,575,579,588],"malignancies":[56,62,123],"has":[57,88,124],"been":[58,89,125],"detected":[59,90],"B-cell":[61,65,73,411,435],"acute":[66],"lymphoblastic":[67],"leukemia":[68,78],"(B-ALL),":[69],"diffuse":[70],"large":[71],"lymphoma":[74,83,436],"(DLBCL),":[75],"chronic":[76],"lymphocytic":[77],"(CLL),":[79],"mantle":[81,309],"(MCL).":[84],"Furthermore,":[85,263],"upregulated":[86],"various":[92],"solid":[93,121,260,379,533],"tumors,":[94],"including":[95,437],"ovarian":[96],"cancer,":[97,107],"breast":[98,103],"adenocarcinomas":[99],"encompassing":[100],"triple":[101],"negative":[102],"(TNBC),":[105],"pancreatic":[106],"Ewing's":[108],"sarcoma":[109],"lung":[111],"adenocarcinoma.":[112],"The":[113,135,487,536],"increased":[114,245],"hematological":[119,258],"associated":[126],"with":[127,234,244,255,366,419,452,466,585],"proliferation,":[129],"poor":[132],"clinical":[133],"outcomes.":[134],"autologous":[136],"UltraCAR-T\u00ae":[137],"platform":[138,183],"designed":[140],"to":[141,151,187,299,354,506],"overcome":[142],"limitations":[144],"traditional":[146],"CAR":[147],"T":[148,154],"which":[149],"leads":[150],"an":[152,304,494],"exhausted":[153],"phenotype,":[156],"high":[157,433],"manufacturing":[158,173],"costs,":[159],"delays,":[162],"using":[163],"advanced":[164,367,445],"non-viral":[165],"gene":[166,230],"delivery":[167],"system":[168],"decentralized,":[171],"overnight":[172],"process.":[174],"Scientific":[175],"Rationale:":[176],"PRGN-3007":[177,235,264,331,361,566,580],"built":[179],"on":[180],"Precigen's":[181],"UltraCAR-T":[182,236,362],"engineered":[186],"simultaneously":[188],"express":[189],"ROR1-specific":[191],"chimeric":[192],"antigen":[193],"(ROR1":[195],"CAR);":[196],"membrane":[197],"bound":[198],"interleukin-15":[199],"(mbIL15)":[200],"enhanced":[202],"vivo":[204],"expansion":[205,352,503,548,568],"persistence;":[207],"kill":[209,272],"switch":[210,273],"improved":[212,290],"safety":[213,357,576],"profile;":[214],"novel":[217],"mechanism":[218],"intrinsic":[221],"blockade":[222],"programmed":[224],"death":[226],"protein":[227],"(PD-1)":[229],"expression.":[231],"Preclinical":[232],"studies":[233],"cells":[237,363,581],"showed":[238],"significant":[239],"reduction":[240],"PD-1":[242,318],"specific":[247,589],"cytotoxicity":[248],"inflammatory":[250],"cytokine":[251],"production":[252],"upon":[253],"co-culture":[254],"ROR1+":[256],"PD-L1+":[257],"cells.":[262],"was":[265],"selectively":[266],"effectively":[268,284],"eliminated":[269],"by":[270,464,500],"activator":[274],"antibody":[275],"treatment.":[276],"In":[277,571],"vivo,":[278],"single":[280],"administration":[281],"PRGN-3007,":[283],"reduced":[285],"burden":[287],"significantly":[289],"overall":[291],"survival":[292],"(p<0.05)":[293],"bearing":[296,334],"mice":[297],"compared":[298],"Control":[300],"CAR-T":[302],"aggressive":[305],"xenograft":[306],"model":[307],"lymphoma.":[311],"Blood":[312],"analyses":[313],"demonstrated":[314],"sustained":[315],"downregulation":[316],"expression,":[319],"rapid":[320],"expansion,":[321],"long-term":[322],"persistence,":[323],"predominant":[326],"central":[327],"memory":[328],"phenotype":[329],"mice.":[335],"(Blood":[336],"(2021)":[337],"138":[338],"(Supplement":[339],"1):":[340],"1694.)":[341],"Study":[342,459],"Design:":[343],"This":[344],"first-in-human,":[347],"Phase":[348],"1/1b":[349],"dose":[350,496,502,508,513,547],"escalation/dose":[351],"study":[353,488],"evaluate":[355],"effectiveness":[359,578],"patients":[365],"ROR1-postive":[368],"(ROR1+)":[369],"hematologic":[370,529],"(CLL,":[371],"MCL,":[372],"ALL,":[373],"DLBCL;":[375],"Arm":[376,382],"1)":[377,477],"tumors":[380],"(TNBC;":[381],"2).":[383,486],"Key":[384],"inclusion":[385],"criteria":[386],"include":[387],"absolute":[388],"lymphocyte":[389],"count":[390],"\u2265":[391],"0.2k/\u00b5L,":[392],"KPS":[393],">":[394],"70,":[395],"adequate":[396],"organ":[397],"function,":[398],"confirmed":[399,409,417,430,450],"and:":[403],"relapsed":[404],"or":[405,424,432,443,447,478],"refractory":[406],"CLL;":[407],"pathologically":[408,416,429],"ALL":[410],"precursor":[412],"measurable":[414,453],"disease,":[415],"MCL":[418],"overexpression":[420],"cyclin":[422],"D1":[423],"presence":[425],"t":[427],"(11;14);":[428],"DLBCL":[431],"grade":[434,441],"transformation":[438],"from":[439],"low":[440],"lymphoma;":[442],"locally":[444],"unresectable":[446],"metastatic":[448],"histologically":[449],"TNBC":[451],"disease":[454,563],"per":[456],"RECIST":[457],"1.1.":[458],"subjects":[460,526,554],"undergo":[461],"leukapheresis":[462],"followed":[463,499,557],"lymphodepletion":[465],"either":[467],"fludarabine":[468],"30mg/m2":[469],"cyclophosphamide":[471,481],"500mg/m2":[472],"3":[474],"days":[475,484],"(Arm":[476,485],"60":[479],"mg/kg":[480],"2":[483,492],"will":[489,521,541,555,582],"enroll":[490],"phases:":[493],"initial":[495],"escalation":[497,514],"phase":[498,515,549],"phase.":[504],"Up":[505],"4":[507],"levels":[509],"are":[510],"planned":[511],"(Table":[516],"1),":[517],"MTD":[520,537],"be":[522,542,556,583],"determined":[523],"separately":[524],"arm":[530,540],"arm.":[535],"each":[539],"expanded":[543],"independently":[544],"study.":[552],"All":[553],"adverse":[559],"events,":[560],"CAR-T-related":[561],"toxicities,":[562],"response":[564,591],"persistence.":[570],"addition,":[572],"mechanisms":[574],"evaluated":[584],"correlative":[586],"assays":[587],"immune":[590],"pathways.":[592],"Figure":[593],"1View":[594,597],"largeDownload":[595,598],"PPTFigure":[596],"PPT":[599],"Close":[600],"modal":[601]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2022-11-30T00:00:00"}